Pre-emptive and continuous inhaled NO counteracts the cardiopulmonary consequences of extracorporeal circulation in a pig model.
Cardiopulmonary bypass (CPB) activates a systemic inflammatory response characterized clinically by alterations in cardiovascular and pulmonary function. The aim of this study was to measure the cardiopulmonary consequences in sham-operated pigs, and in animals subjected to CPB in the presence or absence of lipopolysaccharide (LPS). We also investigated, if the perioperative administration of inhaled NO exerts significant cardiopulmonary effects in an anaesthetized and mechanically ventilated pig model of extracorporeal circulation. Thirty pigs were randomized into six equal groups (sham; sham+INO; CPB; CPB+INO; CPB+LPS; CPB+LPS+INO) and subjected to anaesthesia with mechanical ventilation for up to 24h. We found that CPB+LPS group has the highest degree of lung injury. We also demonstrated that there was a significant difference on the cardiovascular parameters (heart rate, central venous pressure, stroke volume index, and mean systemic arterial blood pressure) between the CPB groups and the sham groups. The deteriorated lung mechanics was associated with a decrease in active subfraction of surfactant (LA) with time during the procedure (P=0.0003), on which inhaled NO had only an initial beneficial effect. In our model, inhaled NO had no long-term beneficial effect on lung mechanics and surfactant homeostasis despite improving lung haemodynamics, inflammation, and oxygenation. We conclude from this study that the use of pre-emptive and continuous inhaled NO therapy has protective and safe effects against lung ischemia/reperfusion associated with CPB.
Troncy
Eric
E
Unit of Anaesthesiology/Pharmacology, Department of Veterinary Biomedicine, Faculty of Veterinary Medicine, Université de Montréal, St-Hyacinthe, Que., Canada.
Hubert
Bernard
B
Pang
Daniel
D
Taha
Rame
R
Gauvin
Dominique
D
Beauchamp
Guy
G
Veldhuizen
Ruud A W
RA
Blaise
Gilbert A
GA
D000280:Administration, Inhalation; D000818:Animals; D001992:Bronchoalveolar Lavage Fluid / Q000166:cytology; D002315:Cardiopulmonary Bypass; D006439:Hemodynamics / Q000187:drug effects*; D007958:Leukocyte Count; D008070:Lipopolysaccharides / Q000633:toxicity; D008168:Lung / Q000098:blood supply* / Q000187:drug effects*; D008297:Male; D023421:Models, Animal; D009569:Nitric Oxide / Q000008:administration & dosage*; D019990:Perioperative Care; D011659:Pulmonary Gas Exchange / Q000187:drug effects; D011663:Pulmonary Surfactants / Q000032:analysis; D015427:Reperfusion Injury / Q000517:prevention & control*; D013552:Swine
D008070:Lipopolysaccharides; D011663:Pulmonary Surfactants; D009569:Nitric Oxide